- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: vemurafenib
Total 160 results
-
UNICANCERHoffmann-La Roche; National Cancer Institute, France; Fondation ARCActive, not recruitingSolid Tumors | Hematologic Cancers | Metastatic CancersFrance
-
Craig L Slingluff, JrNational Cancer Institute (NCI)Terminated
-
University College, LondonHoffmann-La RocheActive, not recruitingNon-small Cell Lung CancerUnited Kingdom
-
Hoffmann-La RocheFoundation Medicine, Inc.Active, not recruitingCancer of Unknown Primary SiteUnited Kingdom, Korea, Republic of, France, Australia, Germany, Austria, Croatia, Denmark, Finland, Greece, Hungary, Italy, Portugal, Spain, Japan, Brazil, Colombia, Mexico, Romania, Czechia, Norway, Thailand, Switzerland, Turkey, Nethe... and more
-
M.D. Anderson Cancer CenterGenentech, Inc.Active, not recruiting
-
Fondazione per la Medicina PersonalizzataActive, not recruitingBreast Cancer | Non Small Cell Lung Cancer | Gastrointestinal Cancer | Other CancerItaly
-
Technische Universität DresdenTerminatedBrain Metastases | Malignant Melanoma Stage IV | BRAF V600 MutationGermany
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); Northwestern University; Northwell Health; Dana-Farber... and other collaboratorsActive, not recruitingHairy Cell LeukemiaUnited States
-
Memorial Sloan Kettering Cancer CenterGenentech, Inc.Active, not recruiting
-
University Hospital, EssenActive, not recruiting
-
Peter MacCallum Cancer Centre, AustraliaTerminated
-
Novartis PharmaceuticalsCompleted
-
Sun Yat-sen UniversityCompletedColorectal Cancer MetastaticChina
-
H. Lee Moffitt Cancer Center and Research InstituteExelixisCompleted
-
University Hospital TuebingenTerminatedMetastatic Melanoma (Carrying BRAF V600 Mutation)Germany
-
Netherlands Working Group on Immunotherapy of OncologyHoffmann-La Roche; Amsterdam UMC, location VUmc; The Netherlands Cancer InstituteTerminated
-
AstraZenecaQuintiles, Inc.CompletedNon Small Cell Lung CancerKorea, Republic of, Spain, France
-
Sunnybrook Health Sciences CentreActive, not recruiting
-
Dana-Farber Cancer InstituteEli Lilly and CompanyActive, not recruiting
-
Hoffmann-La RocheCompletedMalignant MelanomaUnited States, Spain, Hungary, Israel, United Kingdom, Australia, Austria, Belgium, Czechia, France, Germany, Italy, Netherlands, Russian Federation, Sweden, Switzerland, Canada, New Zealand, Norway
-
Fondazione Melanoma OnlusCompleted
-
CytomX TherapeuticsCompletedLymphoma | Solid TumorUnited States, Netherlands, Poland, Spain, Ukraine, United Kingdom
-
Yana NajjarMerck Sharp & Dohme LLCTerminatedMelanomaUnited States
-
Intergruppo Melanoma ItalianoActive, not recruiting
-
Fondazione Melanoma OnlusRoche S.p.aTerminatedMelanoma | Melanoma (Skin) | Melanoma StageItaly
-
Amsterdam UMC, location VUmcCompletedCancer | Advanced Solid TumorsNetherlands
-
Novartis PharmaceuticalsCompletedMelanomaUnited States, United Kingdom, Austria, Belgium, Hungary, Canada, Netherlands, Argentina, Australia, Brazil, Czechia, Denmark, France, Germany, Israel, Italy, Norway, Poland, Russian Federation, Spain, Switzerland, Taiwan, Korea, Republic... and more
-
University Hospital TuebingenTerminatedMalignant MelanomaGermany, France
-
Clinigen, Inc.Prometheus LaboratoriesTerminatedMetastatic MelanomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedMetastatic Malignant Neoplasm | Advanced Malignant Neoplasm | Recurrent Malignant Neoplasm | Refractory Malignant Neoplasm | BRAF Gene MutationUnited States
-
Hoffmann-La RocheCompletedNeoplasmsFrance, Hungary, Spain, Korea, Republic of, United Kingdom, United States, Croatia, Greece, Portugal, Germany, Bosnia and Herzegovina, Belgium, South Africa, Israel, Romania, New Zealand, Italy, Canada, Netherlands, Egypt, Russian... and more
-
Southwest Oncology GroupNational Cancer Institute (NCI); Roche-GenentechCompletedColorectal CancerUnited States
-
Philip FriedlanderGenentech, Inc.TerminatedMelanomaUnited States
-
University of California, San FranciscoNovartisCompletedBRAF Mutant Metastatic MelanomaUnited States
-
Genentech, Inc.Completed
-
M.D. Anderson Cancer CenterCompleted
-
M.D. Anderson Cancer CenterCompletedSolid Tumor | Advanced CancerUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompleted
-
Daiichi Sankyo, Inc.PlexxikonTerminatedV600-mutated BRAF Unresectable Melanoma | V600-mutated BRAF Metastatic Melanoma | Stage III or Stage IV Metastatic Melanoma That Has Not Been Previously Treated With a Selective BRAF InhibitorUnited States, Germany, France
-
Inge Marie SvaneCompleted
-
Grupo Español Multidisciplinar de MelanomaRoche Farma, S.A; Pivotal S.L.Completed
-
Genentech, Inc.CompletedMetastatic Melanoma, BRAF V600 Mutation PositiveKorea, Republic of, Russian Federation, Israel, United States
-
Center Eugene MarquisCompletedMalignant MelanomaFrance
-
Hoffmann-La RocheCompletedMalignant MelanomaSouth Africa
-
Baxter Healthcare CorporationCompletedAdjunct to Hemostasis During Vascular SurgeryRussian Federation
-
National Cancer Institute (NCI)TerminatedMelanoma | Metastatic CancerUnited States
-
Hoffmann-La RocheCompleted
-
Michele SayagCompleted
-
Hoffmann-La RocheCompletedMalignant MelanomaUnited States, Australia
-
Hoffmann-La RocheCompletedMelanomaUnited States, Israel, Italy, Spain, Belgium, United Kingdom, Austria, Czechia, France, Netherlands, New Zealand, Russian Federation, Australia, Canada, Croatia, Portugal, Germany, Ukraine, Switzerland, Argentina, Brazil, Ireland, N... and more